tradingkey.logo
tradingkey.logo
Search

Disc Medicine Inc

IRON
Add to Watchlist
77.000USD
-2.210-2.79%
Close 07-31 16:00ETQuotes delayed by 15 min
2.96BMarket Cap
LossP/E TTM

IRON Cash Flow Statement

You can access the annual and quarterly cash flow statements of Disc Medicine Inc to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
Operating cash flows (indirect method)
Cash flow from continuing operating activities
7.76%-44.20M
-50.42%-62.24M
-57.04%-43.30M
-175.32%-47.80M
-211.30%-47.92M
-23.15%-41.38M
-54.94%-27.57M
-132.22%-17.36M
-20.98%-15.39M
5.26%-33.60M
-43.46%-17.80M
-86.39%-7.48M
-33.97%-12.72M
-158.86%-35.47M
2.08%-12.40M
75.08%-4.01M
40.37%-9.50M
8.70%-13.70M
-5509.21%-12.67M
---16.10M
---15.93M
---15.01M
---225.84K
Net income from continuing operations
-7.76%-59.53M
-86.31%-63.50M
-105.49%-60.53M
-134.30%-62.32M
-109.65%-55.25M
-26.48%-34.09M
-24.93%-29.46M
-88.35%-26.60M
-65.25%-26.35M
-18.30%-26.95M
-11.07%-23.58M
-330.94%-14.12M
-124.92%-15.95M
-131.21%-22.78M
-19.11%-21.23M
82.34%-3.28M
56.89%-7.09M
48.27%-9.85M
-5620.13%-17.82M
---18.55M
---16.45M
---19.05M
---311.58K
Operating gains losses
5.88%90.00K
345.00%89.00K
888.89%89.00K
690.91%87.00K
-22.73%85.00K
-23.08%20.00K
-64.00%9.00K
-56.00%11.00K
340.00%110.00K
4.00%26.00K
-71.91%25.00K
--25.00K
--25.00K
38.89%25.00K
93.48%89.00K
-100.00%0.00
-100.00%0.00
-72.31%18.00K
--46.00K
--58.00K
--62.00K
--65.00K
----
Other non-cash items
78.52%-358.00K
60.33%-952.00K
27.83%-1.51M
35.45%-1.62M
-275.45%-1.67M
-1790.14%-2.40M
-1998.18%-2.09M
-5552.17%-2.51M
-988.00%-444.00K
69.05%142.00K
-47.87%110.00K
--46.00K
--50.00K
13.51%84.00K
--211.00K
--0.00
--0.00
-96.80%74.00K
100.00%0.00
--0.00
--0.00
--2.31M
---3.04K
Change in working capital
405.30%1.43M
12.72%-10.02M
1785.74%8.39M
-14.51%6.33M
-96.07%283.00K
-5.56%-11.48M
-109.54%-498.00K
39.55%7.40M
2024.48%7.20M
21.29%-10.88M
-55.38%5.22M
415.77%5.30M
107.10%339.00K
-231.21%-13.82M
215.14%11.70M
-338.30%-1.68M
-95.62%-4.78M
-3496.55%-4.17M
4082.01%3.71M
--705.00K
---2.44M
---116.00K
--88.78K
-Change in prepaid expenses
435.10%2.28M
37.12%-4.55M
-166.44%-1.38M
-66.49%371.00K
-127.28%-681.00K
-75.83%-7.23M
238.02%2.08M
419.72%1.11M
140.93%2.50M
-352.86%-4.11M
-5296.55%-1.51M
-86.19%213.00K
391.00%1.04M
71.58%-908.00K
-98.14%29.00K
286.68%1.54M
198.14%211.00K
-4.51%-3.19M
3480.76%1.56M
---826.00K
---215.00K
---3.06M
--43.62K
-Change in other current assets
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
-100.00%0.00
600.00%25.00K
-98.17%6.00K
103.89%13.00K
128.44%64.00K
---5.00K
--327.00K
---334.00K
---225.00K
----
-Change in other current liabilities
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--1.17M
---1.17M
--0.00
----
--0.00
--0.00
--0.00
--1.34M
----
Cash from non-recurring investing activities
Cash from operating activities
7.76%-44.20M
-50.42%-62.24M
-57.04%-43.30M
-175.32%-47.80M
-211.30%-47.92M
-23.15%-41.38M
-54.94%-27.57M
-132.22%-17.36M
-20.98%-15.39M
5.26%-33.60M
-43.46%-17.80M
-86.39%-7.48M
-33.97%-12.72M
-158.86%-35.47M
2.08%-12.40M
75.08%-4.01M
40.37%-9.50M
8.70%-13.70M
-5509.21%-12.67M
---16.10M
---15.93M
---15.01M
---225.84K
Investing cash flow
Net cash from continuing investing activities
-100.00%0.00
-100.00%0.00
-95.55%20.00K
425.00%26.00K
1300.00%36.00K
1170.15%851.00K
14866.67%449.00K
-117.78%-8.00K
-125.00%-3.00K
131.03%67.00K
-98.01%3.00K
--45.00K
--12.00K
-71.00%29.00K
1410.00%151.00K
----
----
--100.00K
--10.00K
--61.00K
----
----
----
Capital expenditures
-100.00%0.00
-100.00%0.00
-95.55%20.00K
--26.00K
--36.00K
1170.15%851.00K
14866.67%449.00K
----
----
131.03%67.00K
-98.01%3.00K
--45.00K
--12.00K
-71.00%29.00K
1410.00%151.00K
----
----
--100.00K
--10.00K
--61.00K
----
----
----
Net cash flow from disposal of fixed assets
-100.00%0.00
-100.00%0.00
-95.55%20.00K
425.00%26.00K
1300.00%36.00K
1170.15%851.00K
14866.67%449.00K
-117.78%-8.00K
-125.00%-3.00K
131.03%67.00K
-98.01%3.00K
--45.00K
--12.00K
-71.00%29.00K
1410.00%151.00K
----
----
--100.00K
--10.00K
--61.00K
----
----
----
Net cash flow from business transactions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--415.00K
----
----
----
----
Net cash flow from investment products
-58.18%21.63M
121.45%58.31M
-22711.98%-222.87M
169.71%49.56M
123.54%51.73M
---271.78M
---977.00K
---71.10M
---219.75M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net cash flow from other investing activities
--0.00
--0.00
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
Cash from non-current investing activities
Net cash flow from investing activities
-58.16%21.63M
121.39%58.31M
-15530.65%-222.89M
169.68%49.54M
123.52%51.69M
-406814.93%-272.63M
-47433.33%-1.43M
-157877.78%-71.09M
-1831141.67%-219.75M
-131.03%-67.00K
98.01%-3.00K
---45.00K
---12.00K
71.00%-29.00K
-137.28%-151.00K
----
----
---100.00K
--405.00K
---61.00K
----
----
--0.00
Financing cash flow
Cash flow from continuous financing activities
3525.00%32.34M
-99.31%1.70M
652.43%216.68M
2620.19%11.59M
-99.48%892.00K
1436.17%244.25M
271.19%28.80M
-7.39%426.00K
12.57%173.19M
-79.43%15.90M
-94.97%7.76M
115.80%460.00K
12608.54%153.85M
140456.36%77.31M
13191.09%154.34M
-132.88%-2.91M
22.20%-1.23M
-99.97%55.00K
-117899900.00%-1.18M
---1.25M
---1.58M
--195.49M
---1.00
Net cash flow from debt Issuance/repayment
--29.98M
----
-100.00%0.00
----
----
----
--28.99M
----
----
----
----
----
----
----
533.36%5.42M
-133.36%-2.92M
0.00%-1.25M
----
---1.25M
---1.25M
---1.25M
---833.00K
--0.00
Net cash flow from common stock issuance/repurchase
--0.00
-99.72%687.00K
--206.72M
100.00%0.00
-100.00%0.00
1539.09%243.39M
-100.00%0.00
-8.23%-171.00K
12.99%172.62M
-80.74%14.85M
-87.01%6.95M
---158.00K
--152.78M
--77.08M
--53.50M
----
----
--0.00
----
----
----
----
--0.00
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
--0.00
--0.00
--0.00
--0.00
----
Proceeds from stock option exercised by employees
164.13%2.36M
75.65%1.01M
369.47%5.64M
281.80%1.53M
57.32%892.00K
-28.66%575.00K
49.13%1.20M
-35.11%401.00K
-47.30%567.00K
263.06%806.00K
379.76%806.00K
10200.00%618.00K
5280.00%1.08M
303.64%222.00K
136.62%168.00K
--6.00K
-81.13%20.00K
1275.00%55.00K
--71.00K
--0.00
--106.00K
--4.00K
----
Proceeds from issuance of warrants
----
----
--4.31M
--9.77M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net cash flow from other financing activities
--29.98M
139.37%687.00K
100.00%0.00
48.47%291.00K
--0.00
17.14%287.00K
---1.39M
--196.00K
--0.00
--245.00K
-100.00%0.00
----
----
----
--95.26M
--0.00
100.00%0.00
----
100.00%0.00
--0.00
---437.00K
--196.32M
---1.00
Net cash from non-recurrent financing activities
Net cash from financing activities
3525.00%32.34M
-99.31%1.70M
652.43%216.68M
2620.19%11.59M
-99.48%892.00K
1436.17%244.25M
271.19%28.80M
-7.39%426.00K
12.57%173.19M
-79.43%15.90M
-94.97%7.76M
115.80%460.00K
12608.54%153.85M
140456.36%77.31M
13191.09%154.34M
-132.88%-2.91M
22.20%-1.23M
-99.97%55.00K
-117899900.00%-1.18M
---1.25M
---1.58M
--195.49M
---1.00
Net cash flow
Beginning cash balance
-27.47%89.16M
-52.57%91.39M
-26.95%140.90M
-54.58%127.58M
-64.15%122.91M
-46.57%192.67M
-47.96%192.87M
-25.63%280.90M
44.91%342.85M
85.13%360.62M
599.35%370.66M
247.62%377.72M
98.18%236.60M
120.82%194.79M
-64.76%53.00M
-35.24%108.66M
-35.57%119.39M
1727.87%88.21M
10358.94%150.39M
--167.80M
--185.31M
--4.83M
--1.44M
Current period cash flow changes
109.37%9.76M
96.80%-2.23M
-24413.37%-49.52M
115.14%13.33M
107.53%4.66M
-292.65%-69.76M
97.99%-202.00K
-1146.64%-88.03M
-143.90%-61.95M
-142.49%-17.77M
-107.08%-10.04M
-2.01%-7.06M
1415.43%141.12M
404.17%41.81M
1154.81%141.79M
60.24%-6.92M
38.73%-10.73M
-107.62%-13.75M
-5851.90%-13.44M
---17.41M
---17.51M
--180.48M
---225.84K
Ending cash balance
-22.46%98.92M
-27.47%89.16M
-52.57%91.39M
-26.95%140.90M
-54.58%127.58M
-64.15%122.91M
-46.57%192.67M
-47.96%192.87M
-25.63%280.90M
44.91%342.85M
85.13%360.62M
264.33%370.66M
247.62%377.72M
217.72%236.60M
42.23%194.79M
-32.35%101.74M
-35.24%108.66M
-59.81%74.47M
11198.72%136.95M
--150.39M
--167.80M
--185.31M
--1.21M
Free cash flow
7.83%-44.20M
-47.38%-62.24M
-54.59%-43.32M
-175.47%-47.83M
-211.53%-47.95M
-25.43%-42.23M
-57.44%-28.02M
-130.83%-17.36M
-20.86%-15.39M
5.15%-33.67M
-41.76%-17.80M
---7.52M
---12.74M
-157.19%-35.49M
0.96%-12.56M
----
----
---13.80M
-5513.63%-12.68M
---16.16M
----
----
---225.84K
Currency unit
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
--USD
Audit opinions
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----

FAQs

What is operating cash flow?

Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.

How Much Operating Cash Flow Did Disc Medicine Inc Generate?

Disc Medicine Inc generated -180.39M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.

How Did Disc Medicine Inc's Operating Cash Flow Change Year Over Year?

Disc Medicine Inc's operating cash flow increased by -92.06% year over year.

What is investing cash flow?

Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.

How Much Does Disc Medicine Inc Spend on Capital Expenditures?

Disc Medicine Inc spent 933.00K on capital expenditures in the most recent quarter。

What is financing cash flow?

Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.

How Has Disc Medicine Inc's Financing Cash Flow Changed?

Disc Medicine Inc used 473.41M in financing activities in the latest quarter.

What is free cash flow and why does it matter for IRON?

Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.

What was Disc Medicine Inc’s free cash flow in the latest quarter?

Free cash flow was -181.33M reflecting a -92.02% change from the previous year.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.